Tatva Chintan Pharma IPO Details
Tatva Chintan Pharma Chem IPO description – Tatva Chintan Pharma Chem is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). The company is the largest and only commercial manufacturer of SDAs for zeolites in India while also enjoying the second largest position globally. In addition, the company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe.
The company’s products – 138 as of 31 December 2020 – are used across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. Apart from serving the domestic market, the company exports its products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK. During the nine months ended 31 December 2020, exports of products accounted for 70.7% of its revenue from operations.
Promoters of Tatva Chintan Pharma – Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Shekhar Rasiklal Somani
Tatva Chintan Pharma Chem IPO details | |
Subscription Dates | 16 – 20 July 2021 |
Price Band | INR1,073 – 1,083 per share |
Fresh issue | INR225 crore |
Offer For Sale | INR275 crore |
Total IPO size | INR500 crore |
Minimum bid (lot size) | 13 shares |
Face Value | INR10 per share |
Retail Allocation | 35% |
Listing On | NSE, BSE |
Tatva Chintan Pharma's financial Performance (in INR crore)
 | FY2018 | FY2019 | FY2020 | FY2021 |
Revenue | 137.3 | 206.8 | 264.6 | 306.3 |
Expenses | 118.3 | 180.2 | 217.0 | 245.6 |
Comprehensive income | 12.3 | 20.5 | 37.6 | 52.4 |
Margin (%) | 9.0 | 9.9 | 14.2 | 17.1 |
More about Tatva Chintan Pharma Chem IPO
Registrar of Tatva Chintan Pharma IPO
Link Intime India Private Limited C-101, 1st Floor,
247 Park Lal Bahadur Shastri Marg,
Vikhroli (West) Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Website:Â http://www.linkintime.co.in
Tatva Chintan Pharma Contact Details
Tatva Chintan Pharma Chem Limited
Plot No. 353, Makarpura GIDC,
Vadodara, Gujarat – 390 010
Phone: +91 75748 48533
Email: [email protected]
Website:Â www.tatvachintan.com
Valuation of Tatva Chintan Pharma (as of FY2021)
Earnings Per Share (EPS): INR26.02
Price/Earnings (PE ratio): 41.24 – 41.62
Return on Net Worth (RONW): 31.49%
Net Asset Value (NAV): INR82.62 per share
Tatva Chintan Pharma IPO GMP Daily Trend
Date | Tatva Chintan IPO GMP | Kostak | Subject to Sauda |
28 July 2021 | INR1,150 | – | – |
27 July 2021 | INR1,100 | – | – |
26 July 2021 | INR1,000 | INR450 | INR8,800 |
23 July 2021 | INR900 | INR450 | INR7,800 |
22 July 2021 | INR800 | INR450 | INR7,300 |
21 July 2021 | INR800 | INR450 | INR7,300 |
20 July 2021 | INR700 | INR400 | INR6,800 |
19 July 2021 | INR700 | INR400 | INR6,800 |
17 July 2021 | INR640 | INR350 | INR6,100 |
16 July 2021 | INR620 | INR350 | INR5,700 |
15 July 2021 | INR600 | INR350 | INR5,300 |
14 July 2021 | INR560 | INR340 | INR5,000 |
13 July 2021 | INR500 | INR300 | INR5,000 |
12 July 2021 | INR450 | INR300 | INR5,000 |
Tatva Chintan Pharma IPO Subscription Details
Category | Shares offered | Subscription (no. of times, at 5 PM) | ||
Day 1 | Day 2 | Day 3 | ||
QIB | 9,31,966 | 0.51 | 1.97 | 185.23 |
NII | 6,98,975 | 1.13 | 12.21 | 512.22 |
Retail | 16,30,941 | 8.25 | 23.75 | 35.35 |
 |  |  |  |  |
Total | 32,61,882 | 4.51 | 15.05 | 180.36 |
Tatva Chintan Pharma IPO Review - Broker Views
Angel Broking – Subscribe
BP Wealth – Subscribe
Choice Broking – Subscribe
Elite Wealth – Subscribe
Hem Securities – Subscribe
ICICIdirect – Unrated
Investmentz – Subscribe for long term
KR Choksey – Subscribe
Marwadi Financial Services – Subscribe
Mehta Equities – Subscribe
Motilal Oswal – Subscribe
Reliance Securities – Subscribe
Samco Securities – Subscribe with caution
SMC Global Securities – 2.5/5
Ventura Securities – Subscribe
Tatva Chintan Pharma IPO Allotment Status
Tatva Chintan Pharma IPO allotment status isn’t yet available on Link Intime’s website. Once available, click on this link to get allotment status.
Meanwhile, bank debits have started. Check bank statement for removed lien or amount deduction to know allotment status. Â
Listing Performance of Tatva Chintan Pharma Chem
IPO Opening Date: 16 July 2021
IPO Closing Date: 20 July 2021
Finalisation of Basis of Allotment: 26 July 2021
Initiation of refunds: 27 July 2021
Transfer of shares to demat accounts: 28 July 2021
Listing Date: 29 July 2021
Opening Price on NSE: INR2,111.85 per share (up 95% from IPO price)
Closing Price on NSE: INR2,312.2 per share (up 113.5% from IPO price)
One of the best IPO of Jul after Clean Science & GR Infra
ANY ALLOTMENT
I want to know my ipo details
Tata contain pharma
Best
Best good stock
Hw to relese my blocking amount… I have nt allotment pls rpl